Viral deISGylase activity antagonizes the host innate immune response and enhances coronavirus pathogenesis in a murine model of coronavirus infection 4265

Résumé fourni par la source

Abstract Description Coronaviruses have evolved a breadth of mechanisms to antagonize host innate immune responses. One widely studied mechanism is the ability to deconjugate ISG15 from target proteins in a process called deISGylation, which is catalyzed by the papain-like protease (PLP) domain of viral non-structural protein 3. Since PLP activity is required for viral replication, it has been challenging to generate an infectious virus with a PLP that maintains protease activity but has lost deISGylase activity. In this study, we generated a chimeric MHV-A59 with its PLP2 domain replaced with that of the human coronavirus HKU1, which has been documented to have minimal deISGylase activity in vitro. We determined that the deISGylase-deficient chimera (MHV-HP2) replicates to high titers in IFN-deficient cells but is significantly attenuated in IFN-competent BMDMs compared to WT MHV-A59. We also determined that MHV-HP2 induces a more robust IFN response in BMDMs compared to MHV-A59. Importantly, we report that MHV-HP2 is highly attenuated in vivoand is more rapidly cleared from infected mice compared to MHV-A59. Accordingly, we found that at earlier stages of infection, MHV-HP2 induces a higher IFN response in the liver, providing a potential mechanism for the rapid clearance of the deISGylase-deficient coronavirus. These results document the critical role of viral deISGylase activity as a key contributor to innate immune evasion during coronavirus infection. Funding Sources Supported by R01 AI159945 and R37 AI087846 Topic Categories Viral Immunology (VIR)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.